⚠️ Pitfall alert
- TNBCs can have a range of morphologies
- DCIS is usually absent
- ❌ GATA3
- ✔️ SOX10 (mimic melanoma)
- Always do keratin + review patients history
#Breastpath #Dermpath #Pathtwitter #Pathresidents
⚠️ Pitfall alert
- TNBCs can have a range of morphologies
- DCIS is usually absent
- ❌ GATA3
- ✔️ SOX10 (mimic melanoma)
- Always do keratin + review patients history
#Breastpath #Dermpath #Pathtwitter #Pathresidents
🌴 Papillary, tubular, or solid patterns (occasionally nests).
🔴 Eosinophilic nucleoli resembling inclusions.
⭕ Perinuclear halos.
Image of primary renal tumour in case below
🌴 Papillary, tubular, or solid patterns (occasionally nests).
🔴 Eosinophilic nucleoli resembling inclusions.
⭕ Perinuclear halos.
Image of primary renal tumour in case below
FH is part of the The Citric Acid cycle (TCA), crucial for ATP production.
When mutated or lost (as seen on IHC), fumarate accumulates, creating a pseudo-hypoxic state.
This triggers transcription factors that suppress apoptosis and drive proliferation.
FH is part of the The Citric Acid cycle (TCA), crucial for ATP production.
When mutated or lost (as seen on IHC), fumarate accumulates, creating a pseudo-hypoxic state.
This triggers transcription factors that suppress apoptosis and drive proliferation.
⚠️ NB: In patients with HLRCC, the uterine leiomyomas have a distinct appearance, cutaneous leiomyomas do not ⚠️ .
Sadly, 15-30% of patients with HLRCC will develop this aggressive RCC.
Cutaneous FHD leiomyoma below
⚠️ NB: In patients with HLRCC, the uterine leiomyomas have a distinct appearance, cutaneous leiomyomas do not ⚠️ .
Sadly, 15-30% of patients with HLRCC will develop this aggressive RCC.
Cutaneous FHD leiomyoma below
𝐅𝐇𝐃 𝐑𝐂𝐂 is a rare and highly aggressive tumour with a devastating prognosis—most cases present with metastases at diagnosis. Here’s what to know, a thread 🧵
#pathtwitter #GUpath #Medicine #Oncology #BSTpath
𝐅𝐇𝐃 𝐑𝐂𝐂 is a rare and highly aggressive tumour with a devastating prognosis—most cases present with metastases at diagnosis. Here’s what to know, a thread 🧵
#pathtwitter #GUpath #Medicine #Oncology #BSTpath